FDA Seizure — StemImmune, Inc
The FDA took a Seizure action against StemImmune, Inc on August 25, 2017 (San Diego, CA). The action was issued by CBER and concerns biologics products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- StemImmune, Inc
- Date
- August 25, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Center
- CBER
- Location
- San Diego, CA (United States)